Search

Your search keyword '"Campagnolo M."' showing total 238 results

Search Constraints

Start Over You searched for: Author "Campagnolo M." Remove constraint Author: "Campagnolo M."
238 results on '"Campagnolo M."'

Search Results

1. Immune landscape of the enteric nervous system differentiates Parkinson's disease patients from controls: The PADUA-CESNE cohort

2. Rapidly progressive multiple system atrophy in a patient carrying LRRK2 G2019S mutation

Catalog

Books, media, physical & digital resources

3. Genetic mutations in Parkinson’s disease: screening of a selected population from North-Eastern Italy

4. Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes

5. Neurotransmitter and receptor systems in the subthalamic nucleus

6. Duodenal alpha-Synuclein Pathology and Enteric Gliosis in Advanced Parkinson's Disease

7. Unclassified clinical presentations of chronic inflammatory demyelinating polyradiculoneuropathy

9. The PROVENT-C19 registry: A study protocol for international multicenter SIAARTI registry on the use of prone positioning in mechanically ventilated patients with COVID-19 ARDS

10. Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20)

11. Risk of disease relapse, safety and tolerability of SARS-CoV-2 vaccination in patients with chronic inflammatory neuropathies

12. Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin

13. Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS)

14. The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings

16. A 3‐year interval is too short for re‐screening women testing negative for human papillomavirus: a population‐based cohort study

17. The PROVENT-C19 registry: A study protocol for international multicenter SIAARTI registry on the use of prone positioning in mechanically ventilated patients with COVID-19 ARDS

19. Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity

21. International Guillain-Barré Syndrome Outcome Study

24. Clinician-rated measures for distal symmetrical axonal polyneuropathy: ACTTION systematic review

26. Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin

29. Sporadic hereditary neuropathies misdiagnosed as chronic inflammatory demyelinating polyradiculoneuropathy: Pitfalls and red flags

30. Nerve ultrasound in hereditary transthyretin amyloidosis: red flags and possible progression biomarkers

32. Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNomS study

34. Risk stratification of oxaliplatin induced peripheral neurotoxicity applying electrophysiological testing of dorsal sural nerve

36. PREVALENCE OF ANTI-NEUROFASCIN-155, ANTI-CONTACTIN-1 AND CONTACTIN-ASSOCIATED PROTEIN 1 ANTIBODIES IN CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY: A SEROLOGICAL MULTICENTER STUDY IN ITALY

37. PREVALENCE OF ANTI-NEUROFASCIN-155, ANTI-CONTACTIN-1 AND ANTI-CONTACTIN-ASSOCIATED PROTEIN-1 ANTIBODIES IN CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY: A SEROLOGICAL MULTICENTER STUDY IN ITALY

38. The significance of dorsal sural nerve recordings in early detecting oxaliplatin-induced peripheral neuropathy

39. Rasch-Transformed Total Neuropathy Score clinical version (RT-TNSc©) in patients with chemotherapy-induced peripheral neuropathy

40. International Guillain-Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome

41. Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20)

42. International Guillain-Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome

43. Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20)

45. Long-term plasma exchange in pediatric CIDP

49. Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis